Eleva Biologics
PrivateLast Round
VC Round
Jan 6, 2021
Company Overview
Eleva Biologics operates in Healthcare & Life Sciences and is based in Freiburg. Its latest recorded funding round was a VC Round in January 2021.
Eleva Biologics is a biotechnology company that operates as a clinical-stage biopharmaceutical developer of a novel drug development platform created to produce biologics like antibodies, replacement enzymes, and fusion toxins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eleva Biologics Comparables
Compare Eleva Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyadic International Inc | 77% | |
| Baiya Phytopharm | 77% | |
| Zea Biosciences | 77% |
For institutional investors. Book with your work email.
Eleva Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Eleva Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BORN2GROW | VC Round |
| Schwarz Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2021
$74M round led by BORN2GROW
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 23, 2026
eleva GmbH appoints molecular biologist and entrepreneur Björn Cochlovius as Chief Executive Officer in Germany on May 3rd '23, bringing nearly three decades of scientific, entrepreneurial, and advisory experience to the role.
For institutional investors. Book with your work email.
Eleva Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eleva Biologics's valuation, stock price, and market status.
Is Eleva Biologics a public or private company?
Eleva Biologics is a private company.
What is the current stock price of Eleva Biologics?
Eleva Biologics is a private company, so its shares have no public market price. Caplight tracks Eleva Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eleva Biologics worth (valuation)?
Valuation information for Eleva Biologics is not publicly available.
Can I buy Eleva Biologics stock?
Eleva Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eleva Biologics's last funding round?
Eleva Biologics's most recent funding round was VC Round on January 6, 2021.
Who are the main investors in Eleva Biologics?
Key investors in Eleva Biologics include BORN2GROW.
Will Eleva Biologics IPO soon?
No public IPO plans have been announced for Eleva Biologics.
How can I track Eleva Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Eleva Biologics's shares on secondary markets.